Align Technology Inc
NASDAQ:ALGN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
124.88
239.52
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ALGN
stock under the Base Case scenario is
205.243
USD.
Compared to the current market price of 157.045 USD,
Align Technology Inc
is
Undervalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Align Technology Inc.
| JP |
|
Hoya Corp
TSE:7741
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Increasing competition from lower-cost clear aligner providers and direct-to-consumer brands threatens Align’s primary Invisalign revenue stream, potentially forcing the company to reduce prices and compress margins.
Rising reliance on a recovering economy and discretionary spending makes Align vulnerable to economic downturns, as consumers might postpone nonessential orthodontic treatments when budgets tighten.
Capital-intensive R&D required to stay at the cutting edge of digital dentistry and scanning technologies could strain free cash flow if Align fails to achieve meaningful product differentiation or quickly commercialize new innovations.
Align’s market leadership in clear aligner therapy and substantial brand recognition keep it a top choice among orthodontists, creating pricing power and driving sustained revenue growth.
An expanding global presence and increased dentist adoption of the iTero scanner and associated digital workflows position Align to capture growth in emerging markets while deepening its ties across the entire patient treatment lifecycle.
Continuous investments in R&D, including AI-driven treatment planning and advanced 3D printing technologies, should reinforce Align’s innovation edge, heightening barriers to entry for new competitors.
Revenue & Expenses Breakdown
Align Technology Inc
Balance Sheet Decomposition
Align Technology Inc
| Current Assets | 2.5B |
| Cash & Short-Term Investments | 207.2m |
| Receivables | 1.1B |
| Other Current Assets | 1.2B |
| Non-Current Assets | 3.7B |
| PP&E | 1.3B |
| Intangibles | 590.2m |
| Other Non-Current Assets | 1.8B |
| Current Liabilities | 2B |
| Accounts Payable | 125.6m |
| Accrued Liabilities | 506.8m |
| Other Current Liabilities | 1.3B |
| Non-Current Liabilities | 309.6m |
| Other Non-Current Liabilities | 309.6m |
Free Cash Flow Analysis
Align Technology Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Align Technology Inc
|
Revenue
|
4B
USD
|
|
Cost of Revenue
|
-1.2B
USD
|
|
Gross Profit
|
2.8B
USD
|
|
Operating Expenses
|
-2.1B
USD
|
|
Operating Income
|
646.2m
USD
|
|
Other Expenses
|
-267.6m
USD
|
|
Net Income
|
378.6m
USD
|
ALGN Profitability Score
Profitability Due Diligence
Align Technology Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Align Technology Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
ALGN Solvency Score
Solvency Due Diligence
Align Technology Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Align Technology Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALGN Price Targets Summary
Align Technology Inc
According to Wall Street analysts, the average 1-year price target for
ALGN
is 184.444 USD
with a low forecast of 151.5 USD and a high forecast of 235.82 USD.
Dividends
Current shareholder yield for
ALGN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ALGN
stock under the Base Case scenario is
205.243
USD.
Compared to the current market price of 157.045 USD,
Align Technology Inc
is
Undervalued by 23%.